Dr Manos Nikolousis discusses new drugs now available to treat Acute Myeloid Leukaemia (AML)
AML treatment is moving from being a standard treatment to a personalised treatment. Dr Manos Nikolousis, Clinical Director at Haematology / Stem cell transplantation Heart of England NHS Trust talks about these advancements.
I think the move from standard treatment to personalised treatment is brilliant and definitely the way forward. Thanks for this and take care.
would need a transplant it was my only chance so that's what happened I had my transplant last November...
in three weeks. It has been over a year since treatment, I am worried that the leukaemia has come back...
My dad of 81 years old has been diagnosed with AML and given 6 months to live. He is a very fit man and...
Start a Community